Submitted by Anonymous (not verified) on 1 December 2023 - 15:50
Human medicines European public assessment report (EPAR): Semglee, insulin glargine, Diabetes Mellitus, Date of authorisation: 23/03/2018, Revision: 10, Status: Authorised
Source: